Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 11;4(1):189-199.
doi: 10.1159/000541792. eCollection 2024 Jan-Dec.

ANCA-Negative Pauci-Immune Glomerulonephritis: A Review

Affiliations
Review

ANCA-Negative Pauci-Immune Glomerulonephritis: A Review

Cristián Juanet et al. Glomerular Dis. .

Abstract

Background: Pauci-immune glomerulonephritis (PIGN) is typically secondary to antineutrophil cytoplasmic antibodies (ANCA) small-vessel vasculitis. However, some cases lack detectable circulating ANCA and are called ANCA-negative PIGN (seronegative PIGN). The reported incidence of this varies greatly. Its relationship to ANCA-associated vasculitis (AAV) is unclear.

Summary: This review explores the pathophysiology of seronegative PIGN and summarizes findings from 12 studies focusing on this disease. The role of neutrophils appears to be central, with activation through cellular and humoral mechanisms. Most studies have noted less extrarenal involvement and more chronic changes in the kidney biopsy in seronegative PIGN compared to ANCA-positive cases. Studies have mostly reported using corticosteroids with cyclophosphamide for induction therapy and azathioprine for maintenance. The renal survival was noted to be lower compared to ANCA-positive PIGN.

Key messages: Whether ANCA-negative PIGN represents a distinct disease or is part of the AAV spectrum remains unclear. Prospective large-scale studies are needed to understand this disease for optimal diagnosis and management.

Keywords: ANCA vasculitis; ANCA-negative PIGN; Granulomatosis with polyangiitis; Microscopic polyangiitis; Pauci-immune glomerulonephritis; Seronegative PIGN.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

References

    1. Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. Am J Kidney Dis. 1990;15(6):517–29. - PubMed
    1. Jennette JC, Nachman PH. ANCA glomerulonephritis and vasculitis. Clin J Am Soc Nephrol. 2017;12(10):1680–91. - PMC - PubMed
    1. Chen M, Kallenberg CGM, Zhao M-H. ANCA-negative pauci-immune crescentic glomerulonephritis. Nat Rev Nephrol. 2009;5(6):313–8. - PubMed
    1. Ronsin C, Georges M, Chapelet-Debout A, Augusto J-F, Audard V, Lebourg L, et al. . ANCA-negative pauci-immune necrotizing glomerulonephritis: a case series and a new clinical classification. Am J Kidney Dis. 2022;79(1):56–68.e1. - PubMed
    1. Sethi S, Zand L, De Vriese AS, Specks U, Vrana JA, Kanwar S, et al. . Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis. Nephrol Dial Transpl. 2017;32(Suppl l_1):i139–45. - PubMed

LinkOut - more resources